用于胶质母细胞瘤的下一代嵌合抗原受体 T 细胞疗法。
Next-generation CAR T cell therapies for glioblastoma.
机构信息
Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
出版信息
Sci Transl Med. 2024 Aug 28;16(762):eadp2660. doi: 10.1126/scitranslmed.adp2660.
PMID:39196960
Abstract
Interim results from two phase 1 trials demonstrate progress in the use of chimeric antigen receptor (CAR) T cell therapy for recurrent glioblastoma (GBM).
摘要
两项 1 期临床试验的中期结果表明，嵌合抗原受体（CAR）T 细胞疗法在复发性胶质母细胞瘤（GBM）中的应用取得了进展。
Zotero 插件